Search for: "David Merrell"
Results 1 - 20
of 91
Sorted by Relevance
|
Sort by Date
13 Apr 2007, 6:06 am
David Bernstein will be discussing his latest paper at AEI April 23 at 9:30:In Daubert v. [read post]
28 Dec 2018, 2:22 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), appealed a Ninth Circuit ruling that the Frye rule survived, and was incorporated into, the enactment of a statutory evidentiary rule, Rule 702. [read post]
2 Sep 2009, 7:00 am
Merrell Dow Pharm., Inc. v. [read post]
28 Oct 2014, 7:26 am
Merrell Dow Pharmaceuticals in 1993, creating a new “reliability” test for the admissibility of expert testimony in federal court, interested parties vigorously debated whether Daubert was a lax rule that would favor the admissibility of expert testimony, or a strict rule that would lead to the exclusion of a great deal of previously admissible expert evidence. [read post]
26 Oct 2010, 4:30 am
Merrell Dow Pharmaceuticals, decided by the Supreme Court in 1993. [read post]
28 May 2015, 2:29 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593 (1993). [read post]
6 Nov 2013, 9:52 am
(David Bernstein) I was recently discussing with someone the record of the elite defense bar with regard to the law of expert testimony, and it’s not a happy history. [read post]
16 Mar 2023, 4:30 am
Merrell Dow Pharmaceuticals, Inc., (1993), on the standards for expert testimony, with 24 departing states, United States v. [read post]
22 Feb 2011, 7:27 pm
Maatman, Jr. and David B. [read post]
22 Feb 2011, 7:27 pm
Maatman, Jr. and David B. [read post]
15 Dec 2008, 3:54 pm
District Court Judge David G. [read post]
17 Jun 2022, 2:09 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), legal scholars, judges, and lawyers have struggled with the structure and validity of expert opinion on specific causation. [read post]
28 Dec 2007, 5:17 am
This guest post was written by David Venderbush. [read post]
18 Sep 2011, 9:10 am
(David Bernstein) I’ve noted before that many federal courts simply ignore the text of Federal Rule of Evidence 702 in favor of their own formulations, sometimes relying on cases that were decided before Rule 702 was amended in 2000, and that conflict with the amended rule. [read post]
18 Dec 2009, 11:57 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
30 Jan 2015, 8:19 pm
Merrell Dow Pharma., Inc., 791 F. [read post]
11 Mar 2013, 8:30 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, has solidified that trend. [read post]
17 Mar 2014, 6:57 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
11 May 2019, 3:24 pm
Merrell Dow Pharm., Inc., 509 U.S. 579, 597 (1993); see Fed. [read post]
24 Mar 2017, 8:00 am
David Schwartz, of Innovative Science Solutions, LLC. [read post]
